[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-CLDX":3,"homepage-market-summary":31,"stock-news-CLDX":173},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"CLDX","2026-10-02",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"Celldex Therapeutics, Inc","Nasdaq",null,"IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES","Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.","198","Hampton, NJ",false,{"close":16,"open":17,"high":18,"low":19,"prev_close":20,"change":21,"percent_change":22,"volume":23,"transactions":24,"vwap":25,"high_52w":26,"low_52w":27,"avg_volume_52w":28,"range_52w_percent":29,"record_count":30},31.65,32.26,32.54,30.98,32.18,-0.53,-1.65,2355566.1668,18547,31.6615,45.14,22.1,1004746.198797164,41.4,10174,{"status":32,"indices":33,"watchlist":77,"sectors":99,"benchmarks":155},"success",[34,42,49,56,63,70],{"symbol":35,"name":36,"price":37,"change":38,"pct_change":39,"is_up":40,"sparkline":41,"date":5},"SPX","S&P 500",7722.72,56.27,0.73,true,"0.0,5.0 2.3,8.0 4.6,10.4 6.9,13.4 9.3,9.1 11.6,11.5 13.9,13.8 16.2,16.0 18.5,10.3 20.8,9.5 23.2,2.0 25.5,2.0 27.8,5.9 30.1,6.0 32.4,3.4 34.7,7.3 37.1,8.2 39.4,9.4 41.7,8.5 44.0,4.8",{"symbol":43,"name":44,"price":45,"change":46,"pct_change":47,"is_up":40,"sparkline":48,"date":5},"NDX","NASDAQ 100",30807.93,306.37,1,"0.0,11.5 2.3,11.7 4.6,12.4 6.9,14.8 9.3,12.8 11.6,14.6 13.9,16.0 16.2,15.9 18.5,12.2 20.8,10.7 23.2,4.4 25.5,2.6 27.8,4.5 30.1,4.5 32.4,3.5 34.7,6.0 37.1,5.5 39.4,5.0 41.7,4.3 44.0,2.0",{"symbol":50,"name":51,"price":52,"change":53,"pct_change":54,"is_up":40,"sparkline":55,"date":5},"DJI","DOW JONES",51177,250,0.49,"0.0,2.0 2.3,5.5 4.6,7.8 6.9,9.5 9.3,6.7 11.6,7.5 13.9,9.4 16.2,12.9 18.5,11.1 20.8,11.7 23.2,9.6 25.5,10.7 27.8,12.6 30.1,13.5 32.4,10.8 34.7,12.8 37.1,13.5 39.4,16.0 41.7,15.9 44.0,14.5",{"symbol":57,"name":58,"price":59,"change":60,"pct_change":61,"is_up":40,"sparkline":62,"date":5},"COMP","NASDAQ Composite",27190.86,319.27,1.19,"0.0,10.2 2.3,11.1 4.6,13.0 6.9,14.9 9.3,12.1 11.6,13.7 13.9,16.0 16.2,16.0 18.5,11.1 20.8,10.0 23.2,3.4 25.5,2.0 27.8,5.4 30.1,5.4 32.4,3.9 34.7,6.7 37.1,6.9 39.4,6.2 41.7,6.1 44.0,2.6",{"symbol":64,"name":65,"price":66,"change":67,"pct_change":68,"is_up":40,"sparkline":69,"date":5},"RUT","RUSSELL 2000",2815.2,25,0.9,"0.0,2.0 2.3,3.0 4.6,6.1 6.9,8.4 9.3,7.5 11.6,8.8 13.9,10.4 16.2,11.3 18.5,10.2 20.8,11.2 23.2,10.1 25.5,8.8 27.8,12.9 30.1,13.1 32.4,12.8 34.7,14.4 37.1,15.1 39.4,16.0 41.7,15.1 44.0,13.2",{"symbol":71,"name":72,"price":73,"change":74,"pct_change":75,"is_up":14,"sparkline":76,"date":5},"VIX","CBOE VIX",15.31,-1.08,-6.59,"0.0,14.8 2.3,10.2 4.6,7.3 6.9,2.0 9.3,9.7 11.6,4.9 13.9,4.5 16.2,2.5 18.5,11.3 20.8,13.7 23.2,13.5 25.5,16.0 27.8,12.3 30.1,10.4 32.4,13.5 34.7,8.8 37.1,8.9 39.4,7.8 41.7,7.6 44.0,11.8",[78,85,92],{"symbol":79,"name":80,"price":81,"change":82,"pct_change":83,"is_up":40,"sparkline":84,"date":5},"NVDA","NVIDIA Corp",233.95,3.09,1.34,"0.0,16.0 7.3,15.3 14.7,9.6 22.0,12.1 29.3,10.3 36.7,6.6 44.0,2.0",{"symbol":86,"name":87,"price":88,"change":89,"pct_change":90,"is_up":40,"sparkline":91,"date":5},"AAPL","Apple Inc",333.69,3.37,1.02,"0.0,8.2 7.3,2.0 14.7,5.2 22.0,16.0 29.3,11.7 36.7,14.9 44.0,10.9",{"symbol":93,"name":94,"price":95,"change":96,"pct_change":97,"is_up":40,"sparkline":98,"date":5},"TSLA","Tesla Inc",370.59,16.48,4.65,"0.0,2.0 7.3,5.3 14.7,13.4 22.0,16.0 29.3,14.9 36.7,15.3 44.0,6.1",[100,105,110,115,120,125,130,135,140,145,150],{"name":101,"etf":102,"change":103,"price":104,"is_up":40},"Technology","XLK",1.01,199.81,{"name":106,"etf":107,"change":108,"price":109,"is_up":40},"Financials","XLF",0.06,53.49,{"name":111,"etf":112,"change":113,"price":114,"is_up":14},"Healthcare","XLV",-0.01,166.18,{"name":116,"etf":117,"change":118,"price":119,"is_up":40},"Consumer Cycl","XLY",1.13,110.04,{"name":121,"etf":122,"change":123,"price":124,"is_up":40},"Consumer Staples","XLP",0.25,80.53,{"name":126,"etf":127,"change":128,"price":129,"is_up":40},"Energy","XLE",0.4,62.95,{"name":131,"etf":132,"change":133,"price":134,"is_up":40},"Industrials","XLI",0.78,169.95,{"name":136,"etf":137,"change":138,"price":139,"is_up":40},"Materials","XLB",0.66,48.86,{"name":141,"etf":142,"change":143,"price":144,"is_up":40},"Real Estate","XLRE",0.32,40.81,{"name":146,"etf":147,"change":148,"price":149,"is_up":40},"Utilities","XLU",0.38,39.83,{"name":151,"etf":152,"change":153,"price":154,"is_up":40},"Comm Services","XLC",0.35,110.32,[156,161,165,169],{"ticker":157,"name":158,"price":159,"change":160,"is_up":40},"SPY","SPDR S&P 500 ETF",769.64,0.74,{"ticker":162,"name":163,"price":164,"change":90,"is_up":40},"QQQ","Invesco QQQ Trust",749.58,{"ticker":166,"name":167,"price":168,"change":54,"is_up":40},"DIA","SPDR Dow Jones ETF",511.1,{"ticker":170,"name":171,"price":172,"change":68,"is_up":40},"IWM","iShares Russell 2000",281.52,{"ticker":4,"count":174,"articles":175},19,[176,182,188,194,199,204,210,216,222,228,233,238,243,248,254,259,265,270,276],{"title":177,"link":178,"pubDate":179,"description":180,"source":181},"Celldex Therapeutics (Nasdaq:CLDX) - Stock Analysis - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMikgFBVV95cUxQanJqZjdSRWZzbXNEYXlPdEU3SjI0UTQ0N0MtMzdualBfcDV6UHZfVXNiVHVUcHB1V2JhSkh0Q1A3aFVLQXJQdXRyLTRTQkJueG5sS0JQNjQ3b0FyaEhVSm90Tnp5YmdVZWxfc25ncmI2dmFEb1ZRcm10c2xVbFlWeFZQdUlYdmhRTkhiUGNLN2ZoQQ?oc=5","Sun, 20 Sep 2026 07:00:00 GMT","Celldex Therapeutics (Nasdaq:CLDX) - Stock Analysis Simply Wall Street","Simply Wall Street",{"title":183,"link":184,"pubDate":185,"description":186,"source":187},"Can Celldex (CLDX) Overcome Its Heavy Burn Rate for Long-Term Success? - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMimAFBVV95cUxOa2tlREt5RUYxSUFxUGctS1Vycm9YcWwwUC0yV3V6ZTNqZk1icm4yNkxsT1FZb1JmbTZ3NVZSYkNyWWJLTzYtU0lGaFpNQVNPVFVLU3c5US1TVzBUSzhwQTNsUlJ3VHZNRFNYYmU5dHZpWFFINjRkYUh1ZnBpcjVHa0lpRzZPRHV1NlMyUWl5cUIxa2U2NzRTaA?oc=5","Wed, 23 Sep 2026 07:00:00 GMT","Can Celldex (CLDX) Overcome Its Heavy Burn Rate for Long-Term Success? Yahoo Finance","Yahoo Finance",{"title":189,"link":190,"pubDate":191,"description":192,"source":193},"CLDX Stock Slumps 11% – This Analyst Sees Nearly 90% Upside, Calls Phase 3 Trial Safety Concerns ‘Misplaced’ - Stocktwits","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi0AFBVV95cUxOOUhDeXdESjVEbUtRZjZfVnJtS0pJRmEybFhfd3VqWWY0STY3OE9QNUg0SWtDWDJXdHdLbE5ZY3F3dnotdV9OWmtfVGNRYjBkX0dRaXJRRWhNSUNVMG15MXJpWi1yNTR2YmtPb2VvdlAzRktCTXlNUTVvRmF2WV9QQ3htQmp5WGVxcWtucFVnU3JOTlYyZmkyUTdWNXg0NEVPNi10NkNSYmNKOGhyNTg4UTFsNEF5RDcxREhBS0p5c3lENkNFczIwMzlSRzZ0dnhx?oc=5","Tue, 22 Sep 2026 07:00:00 GMT","CLDX Stock Slumps 11% – This Analyst Sees Nearly 90% Upside, Calls Phase 3 Trial Safety Concerns ‘Misplaced’ Stocktwits","Stocktwits",{"title":195,"link":196,"pubDate":191,"description":197,"source":198},"Celldex stock falls after hives trial data (CLDX:NASDAQ) - Seeking Alpha","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMihwFBVV95cUxQczVxeXBKWGU3VW91MDc1X3lqamJwZTVHQ196Qmx1dGRGOUM4bzdWZlhqdnpkbnRneVdCUFRXOU55aTJZY205blU0RnVMWjlzejNTU1B6UWdoRzZkX1BGanFYQTFVaG9xWlBNbUh1eXBGNlF4YWFrYk1IR2hfR19MYW4xYjdLRms?oc=5","Celldex stock falls after hives trial data (CLDX:NASDAQ) Seeking Alpha","Seeking Alpha",{"title":200,"link":201,"pubDate":191,"description":202,"source":203},"Celldex Therapeutics Shares Fall After Phase 3 Readout Despite Positive Trial Results | CLDX Stock News - Quiver Quantitative","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiugFBVV95cUxQTEdybEpHQ1ozMWtFS2dzR0xUTzNucG02Q0Z1Qy05QmVWU1hESFoyVGxWRno2R0Nla3AydHNlajNYWk1hMklfSE5MWUhqeUZDQjVMR1Nwd3g2ejhjU1ZMRnozc2k1QU5ZMVE5M0JpdmJrNWg3OWdNa0hSN2RQaHFxaFhDb1diMlBseUhHWWF3OE1Bb1RiSHNDZGVfbTJVdlNlMng2OTN3c0J1OUJFbEkwTUItenp3X01CUkE?oc=5","Celldex Therapeutics Shares Fall After Phase 3 Readout Despite Positive Trial Results | CLDX Stock News Quiver Quantitative","Quiver Quantitative",{"title":205,"link":206,"pubDate":207,"description":208,"source":209},"(CLDX) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiygFBVV95cUxNUkQ4VXJjdXlfVDNFZmRaWGw0NlY3dVBkQzNfMm1ZM2FLOFZyalZBNHB5dmtjRnNFaUF2eUJfLVJvSEdMS3dOd1pIb004aFhvdWFRelgtZy14SEVVZXNYZmM1TUJlTm96ZXdxV1g5ZWNTQTF0b0ZMWjVadF93eVYwd0c2c25Kd2U3OXlwNkh4UzVyd2xwak1XeFdzU2NKYWV5T29UWUtRN0FudURvcTU5VU5EUlJac0w5ODBqaFU4eG5GREE0X0pJWHhB?oc=5","Wed, 30 Sep 2026 19:32:02 GMT","(CLDX) as a Liquidity Pulse for Institutional Tactics Stock Traders Daily","Stock Traders Daily",{"title":211,"link":212,"pubDate":213,"description":214,"source":215},"Canaccord Genuity Sticks to Their Buy Rating for Celldex (CLDX) - The Globe and Mail","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi4gFBVV95cUxOV0pEajF6c0w4WFVXMWdhTGJvR1VSLVBCX295LXl1aGhYZnd2bUlrMWdpaGxqbE52ZjYwMFE3Zl9PdnBiQ253aDIzY1BKYl9mU3JJa2FFUjZFMDJCN0hOZE8xcldQTVg5Mk11N3pwWjFZd3FsQ2RlQUo2ZnVDTzFJSDBqRVVmT0xnSkJvREpmbm9iMWtyZkl5UEVMT2tvTzFibDFLdlB4MzVlSDAwOXpPaGFvMmVHOHk5OWJkQUlKZlVkdm13dU1BUW9vVG9pUTg0cFM3d3RFQ1lfeEhDaGlkVzNn?oc=5","Thu, 24 Sep 2026 11:20:00 GMT","Canaccord Genuity Sticks to Their Buy Rating for Celldex (CLDX) The Globe and Mail","The Globe and Mail",{"title":217,"link":218,"pubDate":219,"description":220,"source":221},"Is Celldex Therapeutics, Inc. (CLDX) the Healthcare Stocks Stock Everyone's About to Talk About? - Kalkine Media","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi0gFBVV95cUxNNlotbUFyaF9LZEwyU2VmOXVfY0V5djZucFRWX2lGYkQtZUJuVndLRHNlNjF3R3pqVGZrY1BzaFJhR2JVYzJLZXdzd3UxUktZRWY1dWtKRnRjX29ZNUIydHlWT3BHZnVVeTNob3JiU0pTaGVBcHpBZUgxbDNKWk1ydDhvV3Mtdmpvb0ZxS0lSN3pTWmk3bnlhSEV4RFVBLS1qczEzYlZRb2FIemttZFBFaE8xbmtvOTZiVkJZcHFZaXJmT29DRUdGMGdaMVd5S09manc?oc=5","Fri, 25 Sep 2026 12:30:00 GMT","Is Celldex Therapeutics, Inc. (CLDX) the Healthcare Stocks Stock Everyone's About to Talk About? Kalkine Media","Kalkine Media",{"title":223,"link":224,"pubDate":225,"description":226,"source":227},"H.C. Wainwright Maintains Celldex Therapeutics(CLDX.US) With Buy Rating, Maintains Target Price $64 - Moomoo","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivgFBVV95cUxNNk15dXphUjVpckRKeXl1Z3RBMHlWekFNS0U3cGFjN0pJNUoxRU5NQ0ljMjFHS0t4Z3dnSXg1NzZ4dmRaU3g2bm1OYTVLRUZKc3VIR2Ezb1pOcnN2ZnFseC1Qam90aUZVY3NnZlYtSzRTTkNlQ1JqMzlhc2N4d2lEMm15ZzBHUjRuTXZDUl9JQjFyZnRmbERCQWxaTDZBTl9XRmRDSV80MTFrM0NLMktsanJzU1BoaHZaUExKbDdR?oc=5","Fri, 02 Oct 2026 19:13:32 GMT","H.C. Wainwright Maintains Celldex Therapeutics(CLDX.US) With Buy Rating, Maintains Target Price $64 Moomoo","Moomoo",{"title":229,"link":230,"pubDate":191,"description":231,"source":232},"Why is Celldex Therapeutics stock plummeting today? - Investing.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMisgFBVV95cUxQUFJZMVhlWWNndHlRRl96Z2xCVHYyYlJDOHR3YkNNY0NWajhPbjFYVTd5RnNtLUY4S2RJdWxaQXdvU2drTzZhQTVMRWZ4RG1VbkExXzFqTG0wVzc3MF9CRmJsOEN6V3hRdzYwWWJtOEF0SDUtYTVjdkxab3JsSURIZjFTY3FkbF9YLTFJWXJIR3d4X04yNkJsbDZfOWI0aWNXWllIcHJCV2dmd0JJa0hHd25B?oc=5","Why is Celldex Therapeutics stock plummeting today? Investing.com","Investing.com",{"title":234,"link":235,"pubDate":236,"description":237,"source":181},"Did Phase 3 Trial Success Just Shift Celldex Therapeutics' (CLDX) Investment Narrative? - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Sat, 26 Sep 2026 15:54:04 GMT","Did Phase 3 Trial Success Just Shift Celldex Therapeutics' (CLDX) Investment Narrative? Simply Wall Street",{"title":239,"link":240,"pubDate":185,"description":241,"source":242},"Leerink Partners maintains Outperform rating on Celldex Therapeutics, $88 price target - tradingview.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi3wFBVV95cUxPYndSTFhESFJmdlA1R1NrS1V3Wkd6Nk5XU1RjOHl3Umh6STVWOW93UFEzME9UVHVJZGd5SU1Mbk5LTjlaWXMxMVBmd3Jfbmp5dk5aSHdJZXdFNHQ1eFk3MkxNUkFxWkl5d2hqZzNDV0p0MjlqaGVXcnpMTldyeFhIOFM1eE9vSzdrSDAtWGNDem1yWUhDYTJJSmdXOUZuTmJLeU84OTNhM0tTQkdia3QwZWoxUm5TY3FJVkRZeDkySFNUeGNDSWMtYzR3RDZFa2habDNZcG9xMUNtYzNHV1lv?oc=5","Leerink Partners maintains Outperform rating on Celldex Therapeutics, $88 price target tradingview.com","tradingview.com",{"title":244,"link":245,"pubDate":191,"description":246,"source":247},"4 Biotech Stocks With Key Clinical Readouts Expected This Fall - Zacks Investment Research","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMipgFBVV95cUxNRnVmQS1FZzlrcm5LN19SRl8tZTJlaHZGZDJadXhDZlF6TjRYLTBXcUgxdXJhSFpBbjFRTUpEWmhDalBHNjRDbnlYYm91QmN5MDUzb3VhY0JJbVNPcWJRWEkzUEtTcERWeE42Sk03b295VldCSmdCTzNyYV80YW9QclFJeGlZT2FrcGJKLXpVc3JhMlExNC12MkUxLVJLbi0wQW8zZE5R?oc=5","4 Biotech Stocks With Key Clinical Readouts Expected This Fall Zacks Investment Research","Zacks Investment Research",{"title":249,"link":250,"pubDate":251,"description":252,"source":253},"Celldex Therapeutics stock gains as analysts target USD 56.42 - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivAFBVV95cUxOaGt0UFZTeEt1X29qaUR6N1Z0dldxc3NHNjFEYU1yMGdMQjJ6MTFzTmdTLWNpYWdyeGNEUnZoRW82dXYzRUxIVXJPb2FKVE53ZUdxMFlWdllRNEFac0lUbzU3NXZZbDdkWWVscGUwWkxLUEpNMGVGREdqRXhTSEhEeXFLWEZEYWcybTd1VEJwcnMyWFl1dTZsNTdldnBhLTVReXdUdThRSUFtVFBGTXoxQkNoaG93cjl4X3Yzcw?oc=5","Tue, 22 Sep 2026 06:09:47 GMT","Celldex Therapeutics stock gains as analysts target USD 56.42 AD HOC NEWS","AD HOC NEWS",{"title":255,"link":256,"pubDate":257,"description":258,"source":181},"Is Celldex Therapeutics (CLDX) Fully Priced After Its Phase 3 Win? - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Thu, 24 Sep 2026 22:38:29 GMT","Is Celldex Therapeutics (CLDX) Fully Priced After Its Phase 3 Win? Simply Wall Street",{"title":260,"link":261,"pubDate":262,"description":263,"source":264},"Why is Celldex Therapeutics stock sliding today? By Investing.com - Investing.com UK","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMirAFBVV95cUxNUTl3c3ZxZjQ4NF82WlM2MVJxUUY5UWpHWnQ4TXNvS0lxWTJJemlselNJdm5PaHlRaEM5TkVZSjlrYlNLMDE0aHVPRzNKRExqT3FaLWZYSy1nbDZxbEhpZXpPNmlIUzJ3cnJ1bFRlQmk4SzBXeHdQazQzTXpXaUVaRHdYdzl3OHJMaFBWX0dRM21SRm80Sk1XTDF2dU9OX0oxMHBaNnRPeFZUd0xV?oc=5","Tue, 22 Sep 2026 17:34:00 GMT","Why is Celldex Therapeutics stock sliding today? By Investing.com Investing.com UK","Investing.com UK",{"title":266,"link":267,"pubDate":268,"description":269,"source":181},"Celldex Therapeutics (CLDX) Shares Moved, So What Is Driving Attention Today? - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Wed, 30 Sep 2026 23:27:52 GMT","Celldex Therapeutics (CLDX) Shares Moved, So What Is Driving Attention Today? Simply Wall Street",{"title":271,"link":272,"pubDate":273,"description":274,"source":275},"Celldex Therapeutics Leads Guggenheim’s Biotechnology Rankings By Investing.com - Investing.com Australia","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivwFBVV95cUxPd2Y1SjRwdnQ1bno5Vy1lVTVmZEVLV1Q0YjMtNXdMOW9SOWFHYkVtTThuRnNaRFhqTG04eDZmbFhpQjlyXzVZZlV3ZXJNWVcxajhPV2pmNHBwY3VnY2F4WmFVRGJHNXJhTnBXWXlKbFZGUUMzNGRvMjZ1YXdMcHFmM294d003Z09obnRSTEFQLXJBVnZlWEt1eVh6T2pNNWtpbllsaTVsWlR1VDNvaEZaOFZZazhLZkVaLTlfZFpTaw?oc=5","Wed, 23 Sep 2026 21:52:11 GMT","Celldex Therapeutics Leads Guggenheim’s Biotechnology Rankings By Investing.com Investing.com Australia","Investing.com Australia",{"title":277,"link":278,"pubDate":279,"description":280,"source":281},"Why Celldex Shares Are Suddenly Losing Altitude - TipRanks","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMijwFBVV95cUxPXy1zM1J2VEtIRG5IZnZXbVE3VV85ZnlablEtc24yQktuRGU3bXNwdzByUFFiVlBUM0c5VUUzVGxVSXIwVDFFeDdreUwybDhLdEoyS0M4dU5YR2UwMllZVHdUbVFoSWVtTDlQYXlzLWwzcWxRbWRHaUVrNGc0WF9ZdmJLY1BaZ0pQNUlYMXNmQQ?oc=5","Tue, 22 Sep 2026 11:16:17 GMT","Why Celldex Shares Are Suddenly Losing Altitude TipRanks","TipRanks"]